Zhengye Biotechnology Holding (ZYBT) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Zhengye Biotechnology Holding had return on equity of -25.2% (down from 3.9%), debt-to-equity of 0.24 (down from 0.25), a current ratio of 1.14 (down from 1.31) and return on assets of -9.5% (down from 2.1%). A current ratio of 1.14 means current assets exceed current liabilities.

Zhengye Biotechnology Holding Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Valuation Ratios
P/S Ratio	3.28	-	-	-	-
P/B Ratio	1.24	-	-	-	-
Price/Tangible Book	1.95	-	-	-	-
Price/FCF	30.93	-	-	-	-
Price/OCF	28.59	-	-	-	-
Enterprise Value Ratios
EV/Revenue	4.15	-	-	-	-
EV/FCF	39.19	-	-	-	-
Profitability & Returns
Return on Equity (ROE)	-25.17%	3.89%	10.78%	16.50%	-
Return on Assets (ROA)	-9.48%	2.07%	5.52%	8.53%	-
Return on Invested Capital (ROIC)	-18.83%	3.70%	9.35%	15.22%	13.41%
Return on Capital Employed (ROCE)	-22.30%	4.60%	12.90%	17.90%	16.40%
Leverage & Solvency Ratios
Debt/Equity	0.24	0.25	0.27	0.18	0.09
Debt/EBITDA	-	2.13	1.30	0.77	0.44
Debt/FCF	6.09	3.15	2.20	-	2.35
Liquidity Ratios
Current Ratio	1.14	1.31	1.26	1.41	1.31
Quick Ratio	0.58	0.78	0.77	0.95	0.86
Efficiency Ratios
Asset Turnover	0.25	0.38	0.41	0.54	-
Inventory Turnover	1.90	1.63	1.66	2.27	-
Yield & Distribution Ratios
Earnings Yield	-18.31%	-	-	-	-
FCF Yield	3.23%	-	-	-	-
Payout Ratio	-	141.66%	125.42%	45.84%	28.36%
Buyback Yield	-3.69%	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Zhengye Biotechnology Holding Financial Ratios

What is Zhengye Biotechnology Holding's return on equity?

Zhengye Biotechnology Holding's return on equity (ROE) was -25.2% for fiscal 2025 (period ended Dec 31, 2025). It was 3.9% a year earlier.

What is Zhengye Biotechnology Holding's debt-to-equity ratio?

Zhengye Biotechnology Holding's debt-to-equity ratio was 0.24 for fiscal 2025 (period ended Dec 31, 2025). It was 0.25 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition